Katz Angela, Eifel Patricia J, Jhingran Anuja, Levenback Charles F
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):409-18. doi: 10.1016/s0360-3016(03)00591-1.
To evaluate treatment of the inguinal nodes for patients with squamous cell carcinoma of the vulva.
We reviewed the records of 227 patients who had treatment of the inguinal lymph nodes between 1980 and 1998 for squamous cell carcinoma of the vulva. The inguinal nodes were clinically suspicious in 67 patients and clinically negative in 160. Regional treatment was as follows: lymph node dissection (LND) alone in 119 patients, LND plus radiation therapy (RT) in 57, and RT alone in 51. The extent of LND ranged from node excision to radical inguinal LND; all patients treated with LND alone had at least a superficial inguinal LND. Median follow-up of surviving patients was 98 months. Rates of inguinal node recurrence (INR) at 5 years were calculated using the Kaplan-Meier method.
Thirty-two patients had INRs (5-year INR rate, 15.4%). Patients who received RT alone or RT + LND were significantly more likely than those treated with LND alone to have T3-4 tumors, tumors >5 cm, or lymph node involvement. However, 5-year INR rates were similar for the three groups (16%, 13%, and 16%, respectively). For patients who had LND only, the risk of INR was greater if the primary tumor was more than 2 cm (p = 0.056) or poorly differentiated (p = 0.04). For patients who had postoperative RT, INR was significantly greater if the time from LND to RT was greater than 50 days (p = 0.03). Ten patients had severe groin or lower-extremity complications after LND. Two patients died of postoperative cardiopulmonary complications. Six patients who were treated with RT had hip fractures or hip replacements after treatment.
RT alone or in combination with LND is highly effective in preventing INR in patients with squamous cell carcinoma of the vulva and is associated with a low risk of major late complications.
评估外阴鳞状细胞癌患者腹股沟淋巴结的治疗方法。
我们回顾了1980年至1998年间因外阴鳞状细胞癌接受腹股沟淋巴结治疗的227例患者的记录。67例患者的腹股沟淋巴结临床可疑,160例临床阴性。区域治疗如下:119例患者仅行淋巴结清扫术(LND),57例患者行LND加放射治疗(RT),51例患者仅行RT。LND的范围从淋巴结切除到根治性腹股沟LND;所有仅接受LND治疗的患者至少进行了浅表腹股沟LND。存活患者的中位随访时间为98个月。使用Kaplan-Meier方法计算5年腹股沟淋巴结复发(INR)率。
32例患者发生INR(5年INR率为15.4%)。单独接受RT或RT+LND治疗的患者比仅接受LND治疗的患者更有可能患有T3-4期肿瘤、肿瘤>5 cm或淋巴结受累。然而,三组的5年INR率相似(分别为16%、13%和16%)。对于仅接受LND的患者,如果原发肿瘤大于2 cm(p = 0.056)或分化差(p = 0.04),INR的风险更高。对于接受术后RT的患者,如果从LND到RT的时间大于50天,INR显著更高(p = 0.03)。10例患者在LND后出现严重腹股沟或下肢并发症。2例患者死于术后心肺并发症。6例接受RT治疗的患者在治疗后发生髋部骨折或髋关节置换。
单独RT或与LND联合使用在预防外阴鳞状细胞癌患者的INR方面非常有效,并且主要晚期并发症风险低。